Cellectar Biosciences Director Receives 25,000 Stock Options at $2.70 Exercise Price

Asher Chanan-Khan, a director of Cellectar Biosciences, Inc. (CLRB), received 25,000 stock options on July 7, 2026, with an exercise price of $2.70 per share. The options have a 10-year term expiring on July 7, 2036, and will vest in full on July 7, 2027, contingent upon Chanan-Khan's continued service through that date. This transaction represents an award of derivative securities (Form 4, Code A) with no immediate monetary consideration. Following this transaction, Chanan-Khan holds 25,000 stock options in the company. The filing was signed on July 8, 2026, and reports a non-discretionary transaction by a company director.